ksoulstring

About Kenny Soulstring

Kenny Soulstring is an entrepreneurial visionary with a thirty year history developing and operating small to mid sized businesses. His experience in building a brand led to his interest in investing in small and emerging companies, and for the prior twenty years, his investments allow him to take part in new ventures without undertaking all of the legwork. Focused on finding compelling opportunities in the small cap sector, Soulstring enjoys the art of the build, watching a company develop from concept to maturity. His frequent contact with company management allows him to offer timely and relevant information, working to keep news fresh with a spicy commentary to match. Soulstring was raised in Miami Beach, Florida and plans to retire there when his hair turns fully gray.
Portage Biotech (PTGEF) Stock May Be the Mightiest Micro-Cap in the Market
  • Portage Biotech (PTGEF) Stock May Be the Mightiest Micro-Cap in the Market

Portage Biotech (PTGEF) Stock May Be the Mightiest Micro-Cap in the Market

By |April 17th, 2017|

Portage Biotech Rg (OTCMKTS: PTGEF)

When I first introduced Portage Biotech back in September of 2016, PTGEF was trading at just over twelve cents a share, at which time I made clear my feelings that the stock was grossly undervalued using almost any metric of measurement. At the time, management provided a compelling and informative interview and […]

Can Pluristem Therapeutics (PSTI) Corner The Acute Radiation Syndrome(ARS) Market?
  • Can Pluristem Therapeutics (PSTI) Corner The Acute Radiation Syndrome(ARS) Market?

Can Pluristem Therapeutics (PSTI) Corner The Acute Radiation Syndrome(ARS) Market?

By |April 10th, 2017|

I love the smell of a potentially great micro-cap stock in the morning. And when that potential gem is cash rich, is advancing a late-stage pivotal trial, and has a consistent blessing from the FDA to perpetuate its late-stage trials, then that smell can transform into a fully baked and appetizing investment opportunity. For […]

PTX TEVA IPCI: Trump’s Disdain for Opioid Abuse Favors These Three Companies
  • PTX TEVA IPCI: Trump’s Disdain for Opioid Abuse Favors These Three Companies

PTX TEVA IPCI: Trump’s Disdain for Opioid Abuse Favors These Three Companies

By |April 4th, 2017|

Last week, President Trump made it clear that he is going to take an aggressive stance against the “crippling problem” of opioid drug abuse in the United States. During a White House listening session, Trump reiterated new statistics which show that overdoses are now the leading cause of accidental deaths in the country, with […]

Gaia, Inc. (GAIA) Stock Is Keeping It Peacefully Real
  • Gaia, Inc. (GAIA) Stock Is Keeping It Peacefully Real

Gaia, Inc. (GAIA) Stock Is Keeping It Peacefully Real

By |March 30th, 2017|

At the end of most days, I typically take the opportunity to do what I had forgotten to do for most of the previous twelve hours…stop and take a breath. Ignoring the fact that I remain at least 80% of my former glory- a self-proclaimed, don’t harsh my mellow hippie, there are still some […]

Cancer Genetics, Inc. (CGIX): Don’t Fight the Tape, Stock Going Higher
  • Cancer Genetics, Inc. (CGIX): Don’t Fight the Tape, Stock Going Higher

Cancer Genetics, Inc. (CGIX): Don’t Fight the Tape, Stock Going Higher

By |March 28th, 2017|

Cancer Genetics, Inc. (CGIX) shareholders must certainly be pleased with the stock performance during the prior three trading days. On Monday, shares of CGIX closed higher by over 29%, ending the regular trading session at $5.05 a share. Since the beginning of 2017, shares are now higher by over 260%. With a market cap […]

Pernix (PTX) Stock: An Investors Rationale To Staying Long
  • Pernix (PTX) Stock: An Investors Rationale To Staying Long

Pernix (PTX) Stock: An Investors Rationale To Staying Long

By |March 22nd, 2017|

Pernix Therapeutics Holdings Inc (NASDAQ: PTX)

Let’s keep it real. I am long Pernix stock and, while I may have gotten to the point of where I play hide and seek with the daily share price fluctuations, I am far from throwing in the towel on this company. I’m not stubborn to the point of becoming poor, […]

Meridian Waste Solutions (MRDN) Stock – an Emerging Growth Opportunity in Waste Management
  • Meridian Waste Solutions (MRDN) Stock – an Emerging Growth Opportunity in Waste Management

Meridian Waste Solutions (MRDN) Stock – an Emerging Growth Opportunity in Waste Management

By |March 14th, 2017|

Meridian Waste Solutions, Inc. (NASDAQ: MRDN)

Typically, when a CEO barks that they are not in the business of producing garbage, the connotation is none too friendly. But, for the team at Meridian Waste Solutions, being full of garbage is a rally cry, promoting a sense of pride rather than despair.

Meridian Waste Solutions is not what I […]

AYTU Bioscience (AYTU) Banks $2.2 Million, Will Further Advance Natesto
  • AYTU Bioscience (AYTU) Banks $2.2 Million, Will Further Advance Natesto

AYTU Bioscience (AYTU) Banks $2.2 Million, Will Further Advance Natesto

By |March 1st, 2017|

Aytu Bioscience Inc (OTCMKTS: AYTU)

On Wednesday, Aytu Bioscience announced the successful closing of its warrant tender offer, grossing approximately $2.2 million before customary fee’s and expenses are deducted. Net cash available to AYTU will be approximately $2 million, which is expected to be used for working capital and general corporate purposes.
Strength In AYTU Platform Inspires Confidence
Investors […]

Premier Holdings (PRHL) Stock: Exclusive C-Suite Interview!
  • Premier Holdings (PRHL) Stock: Exclusive C-Suite Interview!

Premier Holdings (PRHL) Stock: Exclusive C-Suite Interview!

By |February 28th, 2017|

Premier Holdings Corp (OTCMKTS: PRHL)

CNA Finance is no stranger when it comes to seeking out emerging opportunities in the markets. And, while the CNA research team generally covers stocks that have valuations in excess of $100 million in market cap, we do entertain investor queries about stocks that are showing signs of having the ability to […]

Aytu BioScience’s (AYTU) “Natesto” to Target Low Testosterone
  • Aytu BioScience’s (AYTU) “Natesto” to Target Low Testosterone

Aytu BioScience’s (AYTU) “Natesto” to Target Low Testosterone

By |February 23rd, 2017|

Aytu BioScience Inc (OTCMKTS: AYTU)

Let’s get an important disclosure out of the way quickly: I am long Aytu BioScience, and for good reason.

Now, while some may argue that this statement is merely an overzealous pitch, it isn’t. In fact, the case for AYTU being a hidden gem is just as powerful as it was in December […]